TGFβ has been shown to inhibit the expression of ATM, mutS homolog 2 (MSH2), and BRCA1 in BT474 breast cancer cells through microRNA, specifically the miR-181 family [77], inducing a BRCAness phenotype. Here, TGFB1 is linked to breast cancer.